معرفی
Regina Mora Vidal is a researcher at Newcastle University with a focus on biochemical mechanisms in cancer therapeutics. Her contributions include:
- Co-authoring studies on kinase inhibition in bladder cancer and CDK2-targeted therapies.
- Collaborations with researchers like Elisa Meschini and Tristan Reuillon.
Research interests center on:
- Protein kinases as therapeutic targets in oncology.
- Irreversible inhibition strategies for cell cycle regulators like CDK2.
- Signal transduction pathways in cancer progression.
The articles indicate a strong emphasis on molecular targeting in cancer, particularly kinase inhibitors and their downstream effects. Collaborative work spans 2014–2018, highlighting translational research in bladder cancer and cell cycle modulation.
۰مقاله منتشرشده